Teleflex (TFX) Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. ONON
5. AAPL
6. NUE
7. RTB
8. AZN
9. SPCX
10. TRMD

Go back to Teleflex (TFX) Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma

Teleflex Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma

February 24, 2021 6:30 AM EST

Submission is eligible for priority review and accelerated approval

WAYNE, Pa., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its investigational freeze dried plasma (FDP) candidate. The investigational FDP is a lyophilized (freeze dried) unit of human plasma being developed under a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Materiel Development Activity... More